维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="Stamp LK"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Starting dose is a risk fac- tor for allopurinol hypersensitivity syndrome : a proposed safe start- ing dose of allopurinol 显示文摘	Stamp LK Taylor W J Jones PB	2012	Arthritis Rheum2012，64，8：	1
2	Lack of asseciation between HLA-G 14 bp insertion/deletion polymorphism and re- sponse to long-term therapywith methotrexate response in rheuma- toid arthritis 显示文摘	Stamp LK O'Donnell JL Chapman PT	2009	Ann Rheum Dis2009，68，1：	1
3	Polymorphisms within the folate pathway predict folate concentrations hut are nol associated with disease activity in rheumatoid arthritis patients on methotrexate 显示文摘	Stamp LK Chapman PT O' Donnell JL	2010	Pharmacogenet Genomics2010，20，6：	1
4	The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region显示文摘	Gibson A Stamp LK Chapman PT	2006	Rheumatology2006，45，5：	1
5	Methotrexate polyglutamate concentrations are not associatedwith disease control in rheumatoid arthritis patient receiving long term methotrexate therapy显示文摘	Stamp LK O'Donnell JL Chapman PT	2010	ArthritisRheum2010，62，2：	1
6	Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol显示文摘	Stamp LK Taylor WJ Jones PB	2012	Arthritis Rheum2012，64，8：	1
7	Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment显示文摘	Stamp LK O'Donnell JL Chapman PT	2009	Arthritis Rheum2009，60，8：	1
8	Leflunomide-Associated Infections in Rheumatoid Arthritis 显示文摘	Jenks KA Stamp LK Odonnell JL	2007	J Rheumatol2007，34，11：	1
9	Phar- macokinetics of oral methotrexate in patients with rheu- matoid arthritis显示文摘	Dalrymple JM Stamp LK O'Donnell JL	2008	Arthritis Rheum2008，58，11：	1
10	Urate- lowering therapy : current options and future prospects for elderly patients with gout显示文摘	Stamp LK Chapman PT	2014	Drugs Aging2014，31，11：	1
11	Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol显示文摘	Stamp LK Taylor WJ Jones PB	2012	Arthritis Rheum2012，64，8：	1
12	Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chro-nic gout,including those with renal impairment显示文摘	Stamp LK O'Donnell JL Zhang M	2011	Arthritis Rheum2011，63，2：	1
13	Leflunomide associated infections in rheumatoid arthritis显示文摘	Jenks KA Stamp LK O'Donnell J L	2007	J Rheumatol2007，34，11：	1
14	Hyperuricaemia and gout in New Zealand rural and urban Māori and non-Māori communities显示文摘	Stamp LK Wells JE Pitama S	2013	Intern Med J2013，43，6：	1
15	Clinically in- significant effect of supplemental vitamin C on serum urate in patients with gout:a pilot randomized controlled trial 显示文摘	Stamp LK O'Donnell JL Frampton C	2013	Arthritis Rheum2013，65，6：	1
16	Monocyte Drived Interleu-kin(lL)-23 Is an Important Determinant of Synovial IL-I7A Expression in Rheumatoid Arthrtis显示文摘	Stamp LK Easson A Pettersson L	2009	J Rheumatol2009，36，11：	1
17	Impaired response or insufficient dosage? Examining the potential causes of 'inadequate response' to allopurinol in the treat- ment of gout 显示文摘	Stamp LK Merriman TR Barclay ML	2014	Semin Arthritis Rheum2014，44，：	1
18	The challenges of gout management in the elderly 显示文摘	Stamp LK Jordan S	2011	Drugs Aging2011，28，8：	1
19	Pharmaeokineties of oral methotrexate in patients with rheumatoid arthritis 显示文摘	Dalrymple JM Stamp LK O' Donnell JL	2008	Arthritis Rheum2008，58，11：	1
20	Determi- nants of red blood cell methotrexate polyglutamate concen- trations in rheumatoid arthritis patients receiving long - term methotrexate treatment 显示文摘	Stamp LK O'Donnell JL Chapman PT	2009	Arthritis & Rheumatism2009，60，8：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示